Skye Bioscience (FRA:09R) Tariff Resilience Score: 5/10 (As of Jul. 08, 2026)


FRA:09R Skye Bioscience Inc FRA:09R
12 GF Score
Price €0.57
! 1 Warning Sign
View Full Analysis

What is Skye Bioscience Tariff Resilience Score?

Skye Bioscience FRA:09R +2.70% 12 Tariff Resilience Score is 5 as of Jul. 08, 2026. GuruFocus rates FRA:09R with a GF Score™ of 12/100. The stock has 1 warning sign investors should review. Among 1,367 Biotechnology companies, Skye Bioscience ranks better than 62.4% on this metric.

Skye Bioscience has the Tariff Resilience Score of 5, which implies that the company might have Average Resilient.

Skye Bioscience has Skye Bioscience, in the biotech sector, faces moderate tariff risks due to reliance on international suppliers for research materials. However, its focus on innovation and potential for industry-specific exemptions provide some resilience.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Skye Bioscience might have Average Resilient.

Skye Bioscience  (FRA:09R) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Skye Bioscience Tariff Resilience Score Related Terms

FRA:09R vs PLRZ, NEUP, LGVN: Tariff Resilience Score Comparison

For the Biotechnology subindustry, Skye Bioscience's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Skye Bioscience Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Skye Bioscience's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Skye Bioscience's Tariff Resilience Score falls into.


FRA:09R
12GF Score
Skye Bioscience Inc FRA:09R
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 5 mean?
Skye Bioscience (FRA:09R) has a Tariff Resilience Score of 5 as of Jul. 08, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Skye Bioscience ranks #514 out of 1367 companies in the Biotechnology industry, placing it in the top 37.6%.
Is Skye Bioscience's Tariff Resilience Score too high?
Skye Bioscience's current Tariff Resilience Score is 5. The Biotechnology industry median Tariff Resilience Score is 4.00. Skye Bioscience's value of 5 is 25% above this industry median. Based on the distribution chart, Skye Bioscience ranks #514 out of 1367 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Skye Bioscience has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Skye Bioscience's Tariff Resilience Score compare to PLRZ and NEUP?
According to the Biotechnology industry distribution chart, Skye Bioscience ranks #514 out of 1367 companies for Tariff Resilience Score. This puts Skye Bioscience in the upper half of its industry. The industry median Tariff Resilience Score is 4.00. Skye Bioscience's value of 5 is 25% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,367 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Skye Bioscience's current Tariff Resilience Score of 5 is 25% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Skye Bioscience's current Tariff Resilience Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Skye Bioscience stock overvalued right now?
Skye Bioscience (FRA:09R) has a current Tariff Resilience Score of 5. The current Tariff Resilience Score is 5 and 25% above the Biotechnology industry median of 4.00. Skye Bioscience's overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Skye Bioscience (FRA:09R), the current Tariff Resilience Score is 5 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Skye Bioscience Business Description

Other Exchanges SKYE:USA
Address 11250 El Camino Real, Suite 100, San Diego, CA, USA, 92130
Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.
12GF Score

Get the complete analysis for FRA:09R

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.57
Price